Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy
Coordination Chemistry Reviews(2022)
摘要
•Various kinds of engineering nanovaccine which could induce immune responses for cancer immunotherapy are discussed.•The barriers and solutions in exocellular and intracellular delivery of antigen have been accentuated.•The clinical practice of nanovaccine has been proposed for application and therapeutic benefits.•Advantages and challenges to use nanovaccine are discussed with highlighting future possibilities.
更多查看译文
关键词
TIL,PRRs,MCs,DCs,MHC I,MHC II,CAR-T,αPD-l,αPD-L1,APCs,IL,TNF-α,OVA,TAAs,IMQ,αCTLA-4,CTLs,MPLA,PLGA NPs,BSA,IFN,HSPCs,AML,ACT,ATRA,TCR,CPP,PEI,PLA,PGA,OVA,SA,STING,CaP,ODN,TNBC,CML,Esp8,MDP,FRβ,TAMs,siRNA,TLR,Poly(I:C),MR,PLL,BMMCs,CCR22,BMDCs,DSPE,PEG,MDSCs,ICG,ICD,DOPE,PAMPs,OMVs,CLRs,RISC,Ago2,STAT3,CSCs,TRP2,EPR,Th,Tregs,MART1,MAGE-A3,PRAME
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要